/
DCF Valuation
Base-case fair value
$1.27
Intrinsic $1.70 · 25% MOS
Current price: $0.49
Base-case summary
Our base-case DCF for Syra Health Corp (SYRA) projects 10 years of free cash flow growth at 8.0% for years 1–5 and 4.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $755968 in trailing free cash flow, this produces an intrinsic value of $1.70 per share. A 25% safety margin gives a fair value of $1.27, suggesting the stock is currently 158% undervalued against the $0.49 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$755968
Cash & equivalents
$3M
Total debt
$73086
Shares outstanding
13M